157 related articles for article (PubMed ID: 28840443)
1. Preoperative Carbohydrate Antigen 19-9: Its Neglected Role in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Lu LH; Zhang YF; Wei W; Shi M; Guo RP
J Gastrointest Surg; 2017 Dec; 21(12):2025-2032. PubMed ID: 28840443
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.
Wan P; Zhang J; Long X; Li Q; Xu N; Zhang M; Chen X; Han L; Xia Q
Eur J Gastroenterol Hepatol; 2014 May; 26(5):553-61. PubMed ID: 24589829
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
Lin K; Huang Q; Zeng J; Ding Z; Wang L; Chen Z; Guo P; Zeng Y; Zhou W; Liu J
Dig Dis Sci; 2021 Dec; 66(12):4545-4556. PubMed ID: 33723698
[TBL] [Abstract][Full Text] [Related]
4. Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
Lu LH; Wei-Wei ; Kan A; Jie-Mei ; Ling YH; Li SH; Guo RP
Dis Markers; 2020; 2020():4269460. PubMed ID: 32695241
[TBL] [Abstract][Full Text] [Related]
5. Elevated preoperative serum CA19-9 levels in patients with hepatocellular carcinoma is associated with poor prognosis after resection.
Chen YL; Chen CH; Hu RH; Ho MC; Jeng YM
ScientificWorldJournal; 2013; 2013():380797. PubMed ID: 23843733
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma.
Sun LY; Cen WJ; Zeng XX; Zhong YY; Deng L; Yang JJ; Li M; Wang F
Am Surg; 2024 Jun; 90(6):1240-1249. PubMed ID: 38214585
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of combined α-fetoprotein and CA19-9 for hepatocellular carcinoma after hepatectomy.
Zhang J; Qin SD; Li Y; Lu F; Gong WF; Zhong JH; Ma L; Zhao JF; Zhan GH; Li PZ; Song B; De Xiang B
World J Surg Oncol; 2022 Oct; 20(1):346. PubMed ID: 36258212
[TBL] [Abstract][Full Text] [Related]
8. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
[TBL] [Abstract][Full Text] [Related]
10. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
[TBL] [Abstract][Full Text] [Related]
12. Carbohydrate Antigen 19-9 Increases the Predictive Efficiency of α-Fetoprotein for Prognosis of Resected Hepatocellular Carcinoma.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
Am Surg; 2018 Jan; 84(1):80-85. PubMed ID: 29428032
[TBL] [Abstract][Full Text] [Related]
13. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
Halazun KJ; Rosenblatt RE; Mehta N; Lai Q; Hajifathalian K; Gorgen A; Brar G; Sasaki K; Doyle MBM; Tabrizian P; Agopian VG; Najjar M; Ivanics T; Samstein B; Brown RS; Emond JC; Yao F; Lerut J; Rossi M; Mennini G; Iesari S; Finkenstedt A; Schaefer B; Mittler J; Hoppe-Lotichius M; Quintini C; Aucejo F; Chapman W; Sapisochin G
JAMA Surg; 2021 Jun; 156(6):559-567. PubMed ID: 33950167
[TBL] [Abstract][Full Text] [Related]
14. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.
Ma WJ; Wang HY; Teng LS
World J Surg Oncol; 2013 Aug; 11():212. PubMed ID: 23981851
[TBL] [Abstract][Full Text] [Related]
15. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
[TBL] [Abstract][Full Text] [Related]
16. Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma.
Muscari F; Guinard JP; Kamar N; Peron JM; Otal P; Suc B
World J Surg; 2012 Aug; 36(8):1824-31. PubMed ID: 22532309
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
18. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
19. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
